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Abstract
Neurodegenerative diseases, including Alzheimer’s disease, are characterized by a progressive and selective loss of neurons. Apoptosis
under mitochondrial control has been implicated in this neuronal death process, involving the release of cytochrome c into the cytoplasm
and initiation of the apoptosis cascade. However, a growing body of evidence suggests an active role for the endoplasmic reticulum in
regulating apoptosis, either independent of mitochondrial, or in concert with mitochondrial-initiated pathways. Members of the Bcl-2
family of proteins have been shown to either inhibit apoptosis, as is the case with Bcl-2, or to promote it, in the case of Bax.
Investigations in our laboratory have focused on neuronal injury resulting from the intracisternal administration of aluminum maltolate to
New Zealand white rabbits, an animal system relevant to a study of human disease in that it reflects many of the histological and
biochemical changes associated with Alzheimer’s disease. Here we report that treatment of young adult rabbits with aluminum maltolate
induces both cytochrome c translocation into brain cytosol, and caspase-3 activation. Furthermore, as assessed by Western blot analysis,
these effects are accompanied by a decrease in Bcl-2 and an increase in Bax reactivity in the endoplasmic reticulum. Ó 2001 Elsevier
Science B.V. All rights reserved.
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1. Introduction early event preceding the formation of these classical
neuropathological features [32]. Mitochondrial changes
Apoptosis, which plays a critical role in the normal following cytotoxic stimuli represent a primary event in
development and maintenance of tissue homeostasis, plays apoptotic cell death, since the apoptogenic factor, cyto-
an important role in neurodegenerative diseases and aging chrome c, is released into the cytoplasm [2,15,20,21].
[26]. Alzheimer’s disease, a common neurodegenerative Once this translocation occurs, cytochrome c binds to
disorder, is characterized typically by intraneuronal neuro- another cytoplasmic factor, Apaf-1, and the formed com-
fibrillary tangles, neuritic plaques and selective neuronal plex activates the initiator caspase-9 that in turn activates
death, with evidence of apoptosis being observed as an the effector caspases, of which caspase-3 is a prominent
member [17,31]. Release of cytochrome c from the
mitochondria has been shown to involve two distinct
*Corresponding author. Tel.: 11-804-924-5682; fax: 11-804-924-
pathways. One implicates the opening of the mitochondria5718.
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gered by the proapoptogenic Bax, is independent of the n56). Al maltolate is soluble at neutral pH, thus avoiding
MTP opening [6]. While Bax has been shown to trigger precipitation of insoluble Al hydroxide as encountered
cell death [7,35], the antiapoptotic Bcl-2 can block cyto- with most of other Al compounds used for neuro-
chrome c release and caspase activation [1,25]. Bcl-2 toxicological studies [29]. The injection was carried out
resides in the mitochondria and prevents activation of the under ketamine anesthesia according to the method de-
effector caspases by mechanisms such as blockade of the scribed previously [27]. Al-treated animals and matched
MTP opening [19,30], or by functioning as a docking controls were sacrificed on days 2 or 3, depending on the
protein [24]. time required for the development of severe neurological
Although Bcl-2 may have a direct action on the mito- symptoms in the Al-treated group. Rabbits were euthan-
chondria, it also resides in the endoplasmic reticulum ized and then perfused with Dulbecco’s phosphate-buf-
[4,36]. A growing body of evidence suggests an active role fered saline (PBS, Gibco, Grand Island, NY) as described
for the endoplasmic reticulum in the regulation of apop- previously [10,11,28]. Brains were immediately removed
tosis. Indeed, stress in the endoplasmic reticulum has been after sacrifice, and a coronal section cut and bisected to
shown to induce apoptosis [34] and, furthermore, the yield two symmetrical hippocampal segments, one for
endoplasmic reticulum induces activation of caspase-12, an immunohistochemistry and the other for immunoblot anal-
effect not triggered by mitochondrial stress [22]. Recently, ysis. The respective sides chosen for these studies were
it has been reported that the drug brefeldin induces alternated between successive animals. Each brain hemi-
endoplasmic reticulum dilatation and leads to cytochrome sphere intended for histology was immediately frozen on a
c release and caspase-3 activation [8]. This effect was liquid nitrogen-cooled surface, placed into a zipper-closure
blocked by the wild-type Bcl-2 and, surprisingly, a Bcl-2 plastic bag, and buried in dry ice pellets until transferring
variant that is exclusively targeted to the endoplasmic to 2808C before sectioning. For immunoblot analysis,
reticulum, was also able to accomplish the same task [8]. tissue from the hippocampus was rapidly dissected,
The authors suggested the existence of ‘cross-talk’ under homogenized and subjected to ultracentrifugation as de-
Bcl-2 control between the endoplasmic reticulum and scribed below.
mitochondria, and that Bcl-2 may exert its protective effect
by controlling calcium homeostasis in the different cell 2.2. Western blot analysis
compartments.
Studies in our laboratory have focused on neuronal Proteins from the mitochondrial, cytosolic and endo-
injury resulting from the intracisternal administration of plasmic fractions were extracted as described previously
aluminum (Al) maltolate to New Zealand white rabbits. [18]. Approximately 100 mg of brain tissue from hip-
This animal system is relevant to a study of human disease pocampus was gently homogenized, using a teflon
in that it reflects many of the histological and biochemical homogenizer (Thomas, Philadelphia PA), in seven volumes
changes associated with Alzheimer’s disease [10]. In the of cold suspension buffer (20 mM Hepes–KOH (pH 7.5),
present study we have investigated the effect of Al 250 mM sucrose, 10 mM KCl, 1.5 mM MgCl , 1 mM2
maltolate-induced neurotoxic injury on cytochrome c EDTA, 1 mM EGTA, 1 mM DTT, 0.1 mM PMSF, 2
release and caspase-3 activation in hippocampus of young mg/ml aprotinin, 10 mg/ml leupeptin, 5 mg/ml pepstatin
adult rabbits. Changes in Bcl-2 and Bax responses in and 12.5 mg/ml of N-acetyl-Leu-Leu-Norleu-Al). The
mitochondria and endoplasmic reticulum were further homogenates were first centrifuged at 7503g at 48C for 5
assessed to determine whether cross-talk between these min, and then at 80003g for 20 min at 48C. The 80003g
intracellular organelles is also involved in the control of pellets were resuspended in cold buffer without sucrose
programmed cell death in this animal system. and used as the mitochondrial fraction. The supernatant
was further centrifuged at 100 0003g for 60 min at 48C to
separate the cytosolic from the endoplasmic reticulum
2. Material and methods fractions. Protein concentrations were determined with the
BCA protein assay reagent (Pierce, Rockford, IL). Proteins
2.1. Animals and treatment (7.5 mg) from the mitochondrial, cytosolic and endo-
plasmic fractions were separated by SDS–PAGE (15% gel)
All animal procedures were in accordance with the US under reducing conditions followed by transfer to a
Public Health Service Policy on Humane Care and Use of polyvinylidene difluoride membrane (Millipore) at 30 mA
Laboratory Animals, and the National Institutes of Health for 210 min in transfer buffer (20 mM Tris-base, 150 mM
Guide for the Care and Use of Laboratory Animals. The glycine, 20% methanol). Following transfer, membranes
animal protocol was approved by the University of Vir- were incubated with mouse monoclonal antibody (mAb) to
ginia Animal Care and Use Committee. Young adult (8–12 human cytochrome c (Pharmingen, San Diego, CA) at a
months old) female New Zealand white rabbits received 1:250 dilution, or to a 1:100 dilution of mAbs recognizing
either intracisternal injections of 100 ml saline (controls, either Bcl-2 or Bax (Santa Cruz Biotechnology, CA).
n56) or 100 ml of 50 mM Al maltolate in saline (treated, Cytochrome oxidase subunit IV (COX) mAb obtained
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from a commercial source (Molecular Probes, Eugene, hydrogen peroxide, with light hematoxylin counterstaining.
OR) was used as a marker of mitochondrial contamination All procedures were performed at room temperature unless
at 1:1000 dilution. A calnexin mAb (Transduction Lab- otherwise noted.
oratories, Lexington, MD) was used at 1:500 dilution as an
endoplasmic reticulum marker, and a mAb to anti-b actin
(Sigma, St. Louis, MO) was used at a 1:250 dilution as a 3. Results
gel loading control. Following washes with Tris-buffered
saline (TBS) containing 0.1% Triton X-100, the blots were 3.1. Western blot analysis
developed using enhanced chemiluminescence (Immun-
Star goat anti-mouse IgG detection kit, Bio-Rad, Hercules, To confirm the purity of the subcellular fractions, we
CA). The bands of cytochrome c, Bax and Bcl-2 which had used antibodies against organelle-specific marker proteins;
been developed on radiographic film, were scanned and cytochrome c oxidase for mitochondria and calnexin for
densitometrically analyzed using Personal Densitometer SI endoplasmic reticulum. As shown in Fig. 1, the fractions
and Image Quant 5.0 software (Molecular Dynamics, were pure, and the b-actin staining, used as a gel loading
Sunnyvale, CA), and these quantitative analyses were control, shows similar protein loading in all the wells.
expressed as mean6S.E.M. values. Unpaired Student’s The immunoreactivity of cytochrome c is evident as a
t-test was used to compare levels of each protein between single band with a molecular weight of 15 kDa. In
controls and Al-treated groups in the same subcellular controls, cytochrome c immunoreactivity is not detectable
fraction. in the cytosolic fraction, but is strongly positive in the
mitochondrial and endoplasmic fractions (Fig. 2A). In the
2.3. Fluorometric assay of caspase-3 activities Al-treated group, cytochrome c is distributed in the
cytosolic, mitochondrial, and endoplasmic reticulum frac-
Lysates were prepared by homogenizing hippocampal tions (Fig. 2B).
tissue in 20 mM Hepes–KOH (pH 7.5), 250 mM sucrose, The antibody to Bcl-2 identifies a protein band with an
10 mM KCl, 1.5 mM MgCl , 1 mM EDTA, 1 mM EGTA, apparent molecular weight of 27 kDa. Bcl-2 is not detected2
1 mM DTT, 0.1 mM PMSF. Lysates were centrifuged for in the cytoplasmic fractions, but relatively intense bands
30 min at 160 0003g and proteins in the supernatant were are found in the mitochondrial and endoplasmic fractions
quantified using the Bradford method. Lysates (50 mg in controls (Fig. 2C). In the Al-treated group, Bcl-2 is
protein) were incubated for 1 h at 378C in 1 ml of 13 restricted to the mitochondria and is barely detected in
Hepes buffer containing 10 ml of the fluorogenic substrate either the cytosolic or endoplasmic reticulum fractions
Ac-DEVD-AMC (Caspase-3 assay kit, Pharmingen, San (Fig. 2D). Bax, with an apparent molecular weight of 21
Diego, CA). Cleavage of the substrate was monitored at an kDa, is distributed in all the fractions, but with a higher
excitation wavelength of 380 nm and emission wavelength intensity in the cytosolic than in the mitochondrial or
of 440 nm using a Model 450 fluorometer (BioMolecular). endoplasmic reticulum fractions (Fig. 2E). In the Al-
Each sample was incubated with or without 10 ml of the
caspase-3 inhibitor Ac-DEVD-CHO (Pharmingen, Saint
Diego, CA). Caspase-3 activity for each sample was
calculated as the difference between the rate of cleavage in
the absence and presence of the inhibitor.
2.4. Immunohistochemistry
Serial 14-mm thick coronal frozen sections from control
and Al-treated animals were cut at the level of the
hippocampus and stored at 2808C prior to immunostain-
ing. The sections were air-dried at room temperature, fixed
in cold acetone for 10 min, treated with 1% hydrogen
peroxide in PBS and incubated with a blocking solution of
1.5% normal serum, also in PBS. Subsequently, sections
were reacted overnight at 48C with a mouse mAb against Fig. 1. Western blot analysis for b-actin, cytochrome c oxidase subunit
caspase-3 (CPP32, Transduction Laboratories, Lexington, IV (COX) and calnexin in cytoplasmic (c), mitochondrial (m) and
endoplasmic reticulum (er) fractions from control hippocampal lysates.KY) at a 1:500 dilution. After washing with 50 mM TBS,
b-Actin, used as a control loading gel, shows similar protein loading inand incubating with the biotinylated secondary antibody,
the mitochondrial, cytoplasmic and endoplasmic reticulum fractions.
sections were processed with a Vectastain Elite avidin– COX, used as a marker for mitochondrial contamination, is only present
biotin complex technique kit (Vector Laboratories, Burl- in the mitochondrial fractions. Calnexin, used as a marker for the
ingame, CA) and visualized by 3,39-diaminobenzidine / endoplasmic reticulum, stains only the endoplasmic reticulum fractions.
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Fig. 2. Representative immunoblots for cytochrome c, Bcl-2 and Bax in controls (A,C,E) and in Al-treated groups (B,D,F) in cytoplasmic (c),
mitochondrial (m) and endoplasmic reticulum (er) fractions from hippocampus lysates. (A) Cytochrome c immunoreactivity is not detected in the cytoplasm
but is highly positive in the mitochondria and endoplasmic reticulum in controls. (B) Al treatment induces translocation of cytochrome c into the
cytoplasm, and positive immunoreactivity for cytochrome c is also detected in the mitochondria and endoplasmic reticulum. (C) Bcl-2 staining, which is
not detected in the cytoplasm, is highly positive in the mitochondrial and endoplasmic reticulum fractions. (D) Following Al treatment, Bcl-2 is decreased
in the mitochondria and is barely detectable in the endoplasmic reticulum. (E) Bax is present in the cytoplasm as well as the mitochondria and endoplasmic
reticulum in controls. (F) In the Al-treated group, Bax immunoreactivity is slightly decreased in the cytoplasm and increased in the mitochondria and
endoplasmic reticulum.
treated animals, Bax immunoreactivity is detectable also in 3.2. Caspase-3 activity
all the fractions; relative amounts are: endoplasmic
reticulum.mitochondria.cytosol (Fig. 2F). The results of The activity of caspase 3-like proteases as assessed by
the densitometric analysis of cytosolic, mitochondrial and measuring the cleavage of the fluorogenic substrate Ac-
endoplasmic reticulum cytochrome c, Bcl-2 and Bax in DEVD-AMC, demonstrates significant elevations in Al-
controls and Al-treated rabbits, are shown in Table 1. treated animals approaching 5-fold greater levels than in
Cytochrome c is absent in the cytoplasm of controls and its the controls (Fig. 3).
intensities in the other fractions are mitochondria.
endoplasmic reticulum. Following Al treatment, cyto-
chrome c is distributed as following, cytoplasm5 3.3. Immunohistochemistry
mitochondria.endoplasmic reticulum. In controls, Bcl-2 is
not present in the cytoplasmic fraction and levels in the The immunohistochemical localization of caspase-3 in
other fractions are mitochondria.endoplasmic reticulum. the pyramidal cell layer of the hippocampus of all animals
In the Al-treated group, Bcl-2 is slightly decreased in the was examined (Fig. 4A). No reaction for caspase-3 is
mitochondria and barely present in the endoplasmic re- observed in sections processed without incubation with
ticulum. In controls, Bax is present in the three subcellular primary antibody (data not shown), or in sections from
fractions as follows: cytoplasm.endoplasmic reticulum. untreated animals (Fig. 4B). In brains from Al-treated
mitochondria. Following the administration of Al maltolate rabbits, there is marked positive immunostaining for
the distribution of Bax is endoplasmic reticulm. caspase-3 in the pyramidal cell layers of the hippocampus
mitochondria.cytoplasm. (Fig. 4C, arrows).
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Table 1 not observed in young adult animals. In the present study,
Densitometric scanning analysis of cytochrome c, Bcl-2 and Bax in the by using a higher concentration of Al maltolate, we now
cytoplasm, mitochondria and endoplasmic reticulum of controls (n56)
report a dramatic effect following Al administration in
and of Al-treated rabbits (n56)
young rabbits. There is considerable support for mito-
Cytoplasm Mitochondria Endoplasmic
chondria playing a key role in the process of cell death,
reticulum
with much attention being focused on cytochrome c. When
Cytochrome c released into the cytoplasm, cytochrome c forms a com-
Controls – 2.060.15 1.6060.18 plex with the cytosolic molecule Apaf-1 and activatesAl-treated 1.7560.16 1.7560.22 0.8560.11
caspase-9 [33,39]. Subsequently, this complex triggers the
Bcl-2
activation of effector caspases, in particular caspase-3 [17].Controls – 1.5060.10 1.2960.16**
Release of cytochrome c from mitochondria into theAl-treated – 1.1060.08 0.1160.06**
cytosol has been reported following brain injury in mice
Bax [21] and addition of the the parkinsonian neurotoxinControls 1.6160.22* 0.7260.13 1.0260.08*
MPP1 to isolated brain mitochondria [2]. The mechanismAl-treated 0.9660.18* 1.0060.10 1.4260.23*
by which cytochrome c is released from mitochondria toWhile cytochrome c is not detectable in the cytoplasm of controls, it is
the cytosol is unclear. It has been suggested that followingreleased into the cytosol following Al treatment. Bcl-2 resides in the
cytotoxic stimuli, the MTP opens and rapidly causesmitochondria and endoplasmic reticulum in controls; Al treatment
decreases Bcl-2 levels in the endoplasmic reticulum. Bax is distributed in depolarization, uncoupling of oxidative phosphorylation,
the cytoplasm.endoplasmic reticulum.mitochondria in controls. Fol- and subsequent pronounced mitochondrial swelling. Sub-
lowing Al administration, Bax is redistributed in the cytoplasm,
sequent events are the diffusion of cytochrome c into the
mitochondria,endoplasmic reticulum.
cytosol through the MTP from its location between the
–, undetectable levels. Data are expressed as mean6S.D. *P,0.05;
inner and outer mitochondrial membranes [19,38]. On the**P,0.01 (Student’s t-test).
other hand, cytochrome c may also translocate from
mitochondria into the cytosol but by a mechanism distinct4. Discussion
from the opening of the MTP. Indeed, it has been shown
that the pro-apoptotic Bax is able to trigger the release ofThe current study provides evidence that neurotoxic
cytochrome c from isolated mitochondria, and that thisinjury, induced in rabbits by the intracisternal administra-
cytochrome c release is not blocked by inhibitors of thetion of Al-maltolate, results in cytoplasmic cytochrome c
MTP opening [6]. Furthermore, it has been reported, intranslocation, endoplasmic reticulum Bcl-2 down-regula-
staurosporine-induced apoptosis of HeLa cells, that Bid, ation and Bax up-regulation, as well as caspase-3 activation.
BH3 domain-containing protein, translocates from theIn a previous report from our laboratory [29] we presented
cytosol to mitochondria and binds to Bax. This directimmunohistochemical evidence for a similar decrease in
binding of Bid to Bax is a prerequisite for Bax structuralthe Bcl-2:Bax ratio, together with evidence of apoptosis, in
changes and subsequent cytochrome c release [5]. Ouraged rabbits treated with Al maltolate, but this effect was
results show that following Al-maltolate treatment, Bax is
redistributed to be present at higher levels in endoplasmic
reticulum and mitochondria than in the cytosol. Changes in
Bax distribution may then initiate cytochrome c release
and caspase-3 activation. However, whether the cyto-
chrome c release we report here results from opening of
the MTP, or from an alternate pathway, remains to be
determined.
Another interesting finding is the observation of de-
creased positivity of the anti-apoptotic protein, Bcl-2, in
the endoplasmic reticulum following Al treatment. This
protein is considered to be a key factor regulating apop-
tosis. It has been shown that Bcl-2-deficient mice under-
went fulminant apoptosis of lymphoid tissue in the thymus
and spleen, while mice overexpressing Bcl-2 demonstrated
extended cell survival [13]. In other studies of cells treated
with staurosporine, overexpression of Bcl-2 has been
demonstrated to prevent the efflux of cytochrome c from
the mitochondria and subsequent initiation of apoptosis
Fig. 3. Caspase-3 activity is shown in hippocampal lysates of controls [37]. In a cell-free apoptosis system, Bcl-2 over-expression(white bar) and Al-treated animals (black bar). In controls, low caspase-3
has also been reported to prevent both the release ofactivity is detected. Al treatment induces a 5.5-fold increase in the
caspase-3 activity. Data are presented as mean6S.E.M. cytochrome c from mitochondria and activation of cas-
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Fig. 4. Immunohistochemical localization of caspase-3 was examined in the pyramidal cell layer of the hippocampus (A, rectangular box). (B) Pyramidal
cell layer of controls shows no immunoreactivity for caspase-3 (3400). (C) Positive immunoreactivity for caspase-3 (arrows) in the pyramidal cell layer in
Al-treated animals (3400). Bar in (C)525 mm.
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Bcl-2 is expressed in neurons that survive focal ischemia in the rat,pases [12]. Bcl-2 has also been found to prolong the life of
NeuroReport 6 (1995) 394–398.rat neurons subjected to ischemia [3] in haloperidol-in- [4] S. Cory, Regulation of lymphocyte survival by the Bcl-2 geneduced neuronal death in the hippocampus of mice [16], and family, Annu. Rev. Immunol. 13 (1995) 513–543.
in a transgenic mouse model of familial amyotrophic [5] S. Desagher, A. Osen-Sand, A. Nichols, R. Eskes, S. Montessuit, S.
lateral sclerosis [14]. Lauper, K. Maundrell, B. Antonsson, J.C. Martinou, Bid-induced
conformational change of Bax is responsible for mitochondrialAs we report here, the ratio of Bcl-2:Bax could be a key
cytochrome c release during apoptosis, J. Cell Biol. 144 (1999)determining factor in the release of cytochrome c, the
891–901.
activation of caspase-3 and in the initiation of apoptosis, [6] R. Eskes, B. Antonsson, A. Osen-Sand, S. Montessuit, C. Richter, R.
since these events are accompanied by an up-regulation of Sadoul, G. Mazzei, A. Nichols, J.C. Martinou, Bax-induced cyto-
the pro-apoptotic Bax and a down-regulation of the anti- chrome C release from mitochondria is independent of the per-
21
meability transition pore but highly dependent on Mg ions, J. Cellapoptotic Bcl-2. Furthermore, as the changes we observed
Biol. 143 (1998) 217–224.for Bcl-2 and Bax mainly were in the endoplasmic
[7] A. Gross, J. Jockel, M.C. Wei, S.J. Korsmeyer, Enforced dimeriza-
reticulum, we suggest that the Bcl-2:Bax ratio in this
tion of Bax results in its translocation, mitochondrial dysfunction
cellular organelle regulates the extent of apoptosis. A and apoptosis, EMBO J. 17 (1998) 3878–3885.
decrease in this ratio may exacerbate apoptosis, and [8] J. Hacki, L. Egger, L. Monney, S. Conus, T. Rosse, I. Fellay, C.
Borner, Apoptotic crosstalk between the endoplasmic reticulum andincreasing this ratio may reverse the deleterious effect of
mitochondria controlled by Bcl-2, Oncogene 19 (2000) 2286–2295.cytotoxic stimuli.
[9] H. He, M. Lam, T.S. McCormick, C.W. Distelhorst, Maintenance ofThe finding of alterations in cytochrome c, Bax and
calcium homeostasis in the endoplasmic reticulum by Bcl-2, J. CellBcl-2 in the present study raises the question as to whether Biol. 138 (1997) 1219–1228.
the mitochondria or endoplasmic reticulum trigger apop- [10] Y. Huang, M.M. Herman, J. Liu, C.D. Katsetos, M.R. Wills, J.
Savory, Neurofibrillary lesions in experimental aluminum-inducedtosis. Recent evidence now implicates the endoplasmic
encephalopathy and Alzheimer’s disease share immunoreactivity forreticulum in this cell death pathway (for a review see Ref.
amyloid precursor protein, Ab, a -antichymotrypsin and ubiquitin-1[23]). In a recent paper, it has been demonstrated that
protein conjugates, Brain Res. 771 (1997) 213–220.
cross-talk between mitochondria and endoplasmic re- [11] C.D. Katsetos, J. Savory, M.M. Herman, R.M. Carpenter, A.
ticulum is controlled by Bcl-2 [8]. Moreover, Bcl-2 is Frankfurter, C.D. Hewitt, M.R. Wills, Neuronal cytoskeletal lesions
suggested to exert its anti-apoptotic effect by maintaining induced in the CNS by intraventricular and intravenous aluminium
maltol in rabbits, Neuropathol. Appl. Neurobiol. 16 (1990) 511–calcium homeostasis in the endoplasmic reticulum [9].
528.In conclusion, we have shown that Al maltolate induces [12] R.M. Kluck, E. Bossy-Wetzel, D.R. Green, D.D. Newmeyer, The
cytochrome c release and caspase-3 activation in young
release of cytochrome c from mitochondria: a primary site for Bcl-2
adult rabbits. These effects are accompanied by a decrease regulation of apoptosis, Science 275 (1997) 1132–1136.
of the anti-apoptotic Bcl-2 and an increase in the pro- [13] S.J. Korsmeyer, X.M. Yin, Z.N. Oltvai, D.J. Veis-Novack, G.P.
Linette, Reactive oxygen species and the regulation of cell death byapoptotic Bax in the endoplasmic reticulum, but the
the Bcl-2 gene family, Biochim. Biophys. Acta 1271 (1995) 63–66.mechanism by which Al maltolate triggers these changes [14] V. Kostic, V. Jackson-Lewis, F. de Bilbao, M. Dubois-Dauphin, S.
remains to be determined. Furthermore, whether cyto- Przedborski, Bcl-2: prolonging life in a transgenic mouse model of
chrome c release from mitochondria precedes changes in familial amyotrophic lateral sclerosis, Science 277 (1997) 559–562.
Bcl-2 and Bax in the endoplasmic reticulum, also remains [15] J.J. Lemasters, A.L. Nieminen, T. Qian, L.C. Trost, S.P. Elmore, Y.
Nishimura, R.A. Crowe, W.E. Cascio, C.A. Bradham, D.A. Brenner,to be ascertained. Nevertheless, our results demonstrate
B. Herman, The mitochondrial permeability transition in cell death:that in young adult rabbit brain, Al is able to trigger
a common mechanism in necrosis, apoptosis and autophagy, Bio-
apoptosis via its action as a neurotoxin.
chim. Biophys. Acta 1366 (1998) 177–196.
[16] F. Lezoualc’h, R. Rupprecht, F. Holsboer, C. Behl, Bcl-2 prevents
hippocampal cell death induced by the neuroleptic drug haloperidol,
Brain Res. 738 (1996) 176–179.Acknowledgements
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